292 related articles for article (PubMed ID: 22922344)
41. Tripterygium wilfordii: An inspiring resource for rheumatoid arthritis treatment.
Zhang Y; Mao X; Li W; Chen W; Wang X; Ma Z; Lin N
Med Res Rev; 2021 May; 41(3):1337-1374. PubMed ID: 33296090
[TBL] [Abstract][Full Text] [Related]
42. In vitro immunosuppressive and cytotoxic activities of Tripterygium wilfordii extract.
He Y; Shi S; Zhang R; Shen W; Tu J; Ding Z; Fan Y
Drug Chem Toxicol; 2015 Apr; 38(2):145-51. PubMed ID: 24845166
[TBL] [Abstract][Full Text] [Related]
43. The Chinese anti-inflammatory and immunosuppressive herbal remedy Tripterygium wilfordii Hook F.
Tao X; Lipsky PE
Rheum Dis Clin North Am; 2000 Feb; 26(1):29-50, viii. PubMed ID: 10680192
[TBL] [Abstract][Full Text] [Related]
44. Suppression of (5R)-5-hydroxytriptolide (LLDT-8) on allograft rejection in full MHC-mismatched mouse cardiac transplantation.
Tang W; Zhou R; Yang Y; Li YC; Yang YF; Zuo JP
Transplantation; 2006 Mar; 81(6):927-33. PubMed ID: 16570019
[TBL] [Abstract][Full Text] [Related]
45. CYP3A4 inducer and inhibitor strongly affect the pharmacokinetics of triptolide and its derivative in rats.
Xu Y; Zhang YF; Chen XY; Zhong DF
Acta Pharmacol Sin; 2018 Aug; 39(8):1386-1392. PubMed ID: 29283173
[TBL] [Abstract][Full Text] [Related]
46. Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents.
Wong KF; Yuan Y; Luk JM
Clin Exp Pharmacol Physiol; 2012 Mar; 39(3):311-20. PubMed ID: 21834865
[TBL] [Abstract][Full Text] [Related]
47. The Chinese herb Tripterygium wilfordii Hook F for the treatment of systemic sclerosis-associated interstitial lung disease: data from a Chinese EUSTAR Center.
Yang L; Wang Q; Hou Y; Zhao J; Li M; Xu D; Zeng X
Clin Rheumatol; 2020 Mar; 39(3):813-821. PubMed ID: 31713733
[TBL] [Abstract][Full Text] [Related]
48. Mechanism for the therapeutic effect of
Zhao J; Liu H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 May; 47(5):573-582. PubMed ID: 35753727
[TBL] [Abstract][Full Text] [Related]
49.
Wang Y; Tian Z; Huang S; Dang N
Drug Des Devel Ther; 2023; 17():3767-3781. PubMed ID: 38144417
[TBL] [Abstract][Full Text] [Related]
50. Triptolide, a novel diterpenoid triepoxide from Tripterygium wilfordii Hook. f., suppresses the production and gene expression of pro-matrix metalloproteinases 1 and 3 and augments those of tissue inhibitors of metalloproteinases 1 and 2 in human synovial fibroblasts.
Lin N; Sato T; Ito A
Arthritis Rheum; 2001 Sep; 44(9):2193-200. PubMed ID: 11592385
[TBL] [Abstract][Full Text] [Related]
51. Triptolide inhibits pancreatic cancer cell proliferation and migration via down-regulating PLAU based on network pharmacology of Tripterygium wilfordii Hook F.
Zhao X; Liu Z; Ren Z; Wang H; Wang Z; Zhai J; Cao D; Lyu S; Li L; Lang R; He Q
Eur J Pharmacol; 2020 Aug; 880():173225. PubMed ID: 32464191
[TBL] [Abstract][Full Text] [Related]
52. [Fingerprint and spectrum-effect relationships on Tripterygium glycosides preparation].
Chi J; Lin B; Liu ZH; Yang LN; Liu XM; Song HT
Zhongguo Zhong Yao Za Zhi; 2015 Apr; 40(8):1479-83. PubMed ID: 26281583
[TBL] [Abstract][Full Text] [Related]
53. A systems pharmacology approach to investigate the mechanisms of action of Semen Strychni and Tripterygium wilfordii Hook F for treatment of rheumatoid arthritis.
Li Y; Wang J; Xiao Y; Wang Y; Chen S; Yang Y; Lu A; Zhang S
J Ethnopharmacol; 2015 Dec; 175():301-14. PubMed ID: 26386382
[TBL] [Abstract][Full Text] [Related]
54. Anti-inflammatory effects and hepatotoxicity of Tripterygium-loaded solid lipid nanoparticles on adjuvant-induced arthritis in rats.
Xue M; Jiang ZZ; Wu T; Li J; Zhang L; Zhao Y; Li XJ; Zhang LY; Yang SY
Phytomedicine; 2012 Aug; 19(11):998-1006. PubMed ID: 22884304
[TBL] [Abstract][Full Text] [Related]
55. [Studies on diterpenoids from leaves of Tripterygium wilfordii].
Zhang CP; Lu XY; Ma PC; Chen Y; Zhang YG; Yan Z; Chen GF; Zheng QT; He CH; Yu DQ
Yao Xue Xue Bao; 1993; 28(2):110-5. PubMed ID: 8328278
[TBL] [Abstract][Full Text] [Related]
56. [Progress in research on triptolide].
Liu MX; Dong J; Yang YJ; Yang XL; Xu HB
Zhongguo Zhong Yao Za Zhi; 2005 Feb; 30(3):170-4. PubMed ID: 15719629
[TBL] [Abstract][Full Text] [Related]
57. Combined multi-omics and network pharmacology approach reveals the role of Tripterygium Wilfordii Hook F in treating HIV immunological non-responders.
Liu X; Lin L; Lv T; Lu L; Li X; Han Y; Qiu Z; Li X; Li Y; Song X; Cao W; Li T
Phytomedicine; 2022 Jul; 101():154103. PubMed ID: 35468451
[TBL] [Abstract][Full Text] [Related]
58. Efficacy and safety of Tripterygium wilfordii hook F for chronic urticaria: a systematic review and meta-analysis.
Liu L; Zhao H; Sun X; Zheng Q; Luo Y; Ru Y; Zhang Y; Chen X; Zhu B; Yin C; Li B; Li X
BMC Complement Altern Med; 2018 Aug; 18(1):243. PubMed ID: 30170584
[TBL] [Abstract][Full Text] [Related]
59. Compatibility with Panax notoginseng and Rehmannia glutinosa Alleviates the Hepatotoxicity and Nephrotoxicity of Tripterygium wilfordii via Modulating the Pharmacokinetics of Triptolide.
Zhang Q; Li Y; Liu M; Duan J; Zhou X; Zhu H
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29351251
[No Abstract] [Full Text] [Related]
60. Dual-function of triptriolide in podocytes injury: inhibiting of apoptosis and restoring of survival.
Yang YQ; Liang J; Han XD; Tian RM; Liu XS; Mao W; Xu HT; Liu B; Xu P
Biomed Pharmacother; 2019 Jan; 109():1932-1939. PubMed ID: 30551448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
